Skip to main content
Erschienen in:

01.06.2019 | Case report

Hydroxycarbamide

Gastrointestinal irritation, neutropenia and thrombocytopenia: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Park H, et al. Effectiveness of hydroxycarbamide in children with sickle cell disease - Analysis of dose-response metrics in a large birth cohort in a tertiary sickle cell centre. Pediatric Blood and Cancer 66: No. 7, Jul 2019. Available from: URL: http://doi.org/10.1002/pbc.27615 - United Kingdom Park H, et al. Effectiveness of hydroxycarbamide in children with sickle cell disease - Analysis of dose-response metrics in a large birth cohort in a tertiary sickle cell centre. Pediatric Blood and Cancer 66: No. 7, Jul 2019. Available from: URL: http://​doi.​org/​10.​1002/​pbc.​27615 - United Kingdom
Metadaten
Titel
Hydroxycarbamide
Gastrointestinal irritation, neutropenia and thrombocytopenia: 4 case reports
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-64027-2